Natco Pharma (BOM:524816) PB Ratio : 3.16 (As of May. 29, 2024)

View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-29), Natco Pharma's share price is ₹1032.30. Natco Pharma's Book Value per Share for the quarter that ended in Mar. 2024 was ₹326.79. Hence, Natco Pharma's PB Ratio of today is 3.16.

The historical rank and industry rank for Natco Pharma's PB Ratio or its related term are showing as below:

BOM:524816' s PB Ratio Range Over the Past 10 Years
Min: 2.11 Med: 3.91 Max: 11.33
Current: 3.16

During the past 13 years, Natco Pharma's highest PB Ratio was 11.33. The lowest was 2.11. And the median was 3.91.

BOM:524816's PB Ratio is ranked worse than
73.79% of 954 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs BOM:524816: 3.16

During the past 12 months, Natco Pharma's average Book Value Per Share Growth Rate was 22.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 13.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 10.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 22.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Natco Pharma was 48.50% per year. The lowest was 7.00% per year. And the median was 18.70% per year.

Back to Basics: PB Ratio

Natco Pharma PB Ratio Historical Data

The historical data trend for Natco Pharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natco Pharma PB Ratio Chart

Natco Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

PB Ratio

Get a 7-Day Free Trial

2.44

3.65

3.24

2.11

2.91

Natco Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
PB Ratio	Get a 7-Day Free Trial															2.11	-	2.95	-	2.91

Competitive Comparison of Natco Pharma's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natco Pharma's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Natco Pharma's PB Ratio falls into.

Natco Pharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Natco Pharma's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Mar. 2024)
	=	1032.30	/	326.788
	=	3.16

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Natco Pharma (BOM:524816) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Natco Pharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Natco Pharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Natco Pharma (BOM:524816) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (BOM:524816) » Definitions » PB Ratio

Traded in Other Exchanges

NATCOPHARM:India

Address

Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034

Website

https://www.natcopharma.co.in

Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma (BOM:524816) Headlines

No Headlines